Telmisartan and Rosuvastatin Tablets 40/5 mg

Adult dose

Telmisartan: It is recommended to take 40 mg orally once daily for essential hypertension, although a dose of 20 mg daily may be effective in some patients. The dose can be increased to 80 mg once daily if necessary. For reducing the risk of cardiovascular disease, 80 mg orally once daily is recommended. Patients with liver dysfunction should not exceed 40 mg daily. Rosuvastatin Calcium: For primary hypercholesterolemia.

This medication may pose significant risks, especially to the fetus and newborn when used during pregnancy, and should not be administered to pregnant women or those who may become pregnant. Patients with allergies to this drug, severe liver or kidney diseases, certain muscle disorders, and congenital lactose intolerance should not take this medication. Elderly patients or those with high potassium levels or impaired liver function, as well as patients with heart or gastrointestinal disorders, should use this medication cautiously and require regular monitoring during treatment. This drug may cause various side effects such as muscle pain, weakness, liver function abnormality, low blood pressure, dizziness, and digestive disorders, so any unusual symptoms should be reported to healthcare professionals immediately. In particular, if muscle-related symptoms or significant changes in blood test levels occur, the medication should be discontinued and a doctor should be consulted. Muscle and liver function tests are recommended before and during treatment. Drug interactions may occur when taken with other medications, so patients must inform their healthcare provider about any other drugs they are taking, especially when combined with certain diuretics, antihypertensives, anticoagulants, immunosuppressants, etc. This medication may cause drowsiness or dizziness when driving or operating machinery, caution is advised. Safety and effectiveness in children have not been established, thus it is not recommended for use in this population. In the event of an overdose, symptoms such as low blood pressure, dizziness, and kidney failure may appear, requiring immediate medical attention. This medication should be stored away from direct sunlight and kept out of reach of children, and it should not be transferred to any other container.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweats, pallor, severe rash with fever, blisters, skin shedding, pain in mouth/eyes mucous membranes, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of skin or eyes, extreme fatigue, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, markedly reduced urine output

Mild side effects

• Indigestion
• oral paresthesia
• musculoskeletal stiffness
• acne
• itching
• dizziness
• nasopharyngitis
• dysuria
• rhinitis
• discomfort in the oropharynx

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

Pale yellow oval film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP X 3]